Research
Hormonal
CagriSema is being marketed as a safe and potentially superior medication to lower both Hemoglobin A1c and body weight.
Practitioners may consider CagriSema as a treatment option for patients needing glycemic control and weight management.
StrongSupportsmedium confidence
This drug is being marketed as a safe and potentially superior medication to lower both Hemoglobin A1c and body weight.
Why this rating
The claim is based on the investigation of a new drug, indicating a high level of research backing.
Source
Advancing Diabetes Management and Glycemic Control While Exploring CagriSema’s Impact on Obesity Management
Somar Hadid et al. · Cardiology in Review · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →